Sun Pharma Advanced Research Company Ltd.
| BSE: 532872 | Sector: Others |
| NSE: SPARC | ISIN Code: INE232I01014 |
| BSE 00:00 | 09 Apr | 167.95 |
6.30 (3.90%) |
OPEN
161.75 |
HIGH
170.55 |
LOW
161.75 |
| NSE 00:00 | 09 Apr | 167.60 |
5.85 (3.62%) |
OPEN
162.00 |
HIGH
170.70 |
LOW
161.75 |
| OPEN | 161.75 |
| PREVIOUS CLOSE | 161.65 |
| VOLUME | 117064 |
| 52-Week high | 209.80 |
| 52-Week low | 106.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 4,400 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Sun Pharma Advanced Research Company Ltd. (SPARC) - Announcements
-
Sun Pharma Advanced Research Company Ltd Submission Of Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Dis
09/04/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
08/04/2021 | bse
-
Sun Pharma Advanced Research Company Ltd Notice Of The Extra-Ordinary General Meeting Of The Company To Be Held On Monday 26Th April 2021 At
01/04/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Closure of Trading Window
30/03/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
06/03/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Update On TACLANTIS? (Paclitaxel Injection Concentrate For Suspension) NDA
23/02/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Update On TACLANTIS? (Paclitaxel Injection Concentrate For Suspension) NDA
23/02/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
20/02/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Outcome Of Board Meeting Held On 8Th February 2021.
08/02/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Outcome Of Board Meeting Held On 8Th February 2021.
08/02/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Board Meeting Intimation for Notice Of Board Meeting For Consideration Of Unaudited Financial Result
29/01/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
28/01/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Shareholding for the Period Ended December 31 2020
15/01/2021 | bse
-
Sun Pharma Advanced Research Company Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
13/01/2021 | bse
-
Sun Pharma Advanced Research Company Ltd Clarification - Increase In Volume
01/01/2021 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Clarification sought from Sun Pharma Advanced Research Company Ltd
01/01/2021 | bse
-
Sun Pharma Advanced Research Company Ltd Closure of Trading Window
30/12/2020 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
09/12/2020 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
09/12/2020 | bse |
Downlaod PDF -
Sun Pharma Advanced Research Company Ltd Disclosure Of Related Party Transactions - September 2020
02/12/2020 | bse |
Downlaod PDF
Quick Links for Sun Pharma Advanced Research Company:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
